ABCG2 and in situ carcinoma: 2.3. Acquisition of Resistance to Cisplatin Increases MDR1 Activity in YD-9/CIS Cells and BCRP Activity in YD-8/CIS, YD-9/CIS, and YD-38/CIS Cells